Ping Mu - Related publications

Affiliations: 
University of Texas Southwestern Medical Center, Dallas, TX, United States 
Area:
Cancer Biology
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
28 most relevant papers in past 60 days:
Year Citation  Score
2022 Qian J, Huang C, Zhu Z, He Y, Wang Y, Feng N, He S, Li X, Zhou L, Zhang C, Gong Y. NFE2L3 promotes tumor progression and predicts a poor prognosis of bladder cancer. Carcinogenesis. PMID 35022660 DOI: 10.1093/carcin/bgac006   
2022 Sun Y, Tian Y, He J, Tian Y, Zhang G, Zhao R, Zhu WJ, Gao P. Linc01133 contributes to gastric cancer growth by enhancing YES1-dependent YAP1 nuclear translocation via sponging miR-145-5p. Cell Death & Disease. 13: 51. PMID 35017464 DOI: 10.1038/s41419-022-04500-w   
2022 Bolatkan A, Asada K, Kaneko S, Suvarna K, Ikawa N, Machino H, Komatsu M, Shiina S, Hamamoto R. Downregulation of METTL6 mitigates cell progression, migration, invasion and adhesion in hepatocellular carcinoma by inhibiting cell adhesion molecules. International Journal of Oncology. 60. PMID 34913069 DOI: 10.3892/ijo.2021.5294   
2022 Chen P, Hu J, Han X, Chen Y. Advances in the functional roles of N6-methyladenosine modification in cancer progression: mechanisms and clinical implications. Molecular Biology Reports. PMID 35025029 DOI: 10.1007/s11033-022-07126-5   
2022 Tan Y, Xu F, Xu L, Cui J. Long non‑coding RNA LINC01748 exerts carcinogenic effects in non‑small cell lung cancer cell lines by regulating the microRNA‑520a‑5p/HMGA1 axis. International Journal of Molecular Medicine. 49. PMID 34970695 DOI: 10.3892/ijmm.2021.5077   
2022 Wu T, Yang Y, Zhang B, Zhang ZS, Zhou S, Jia GZ, Liu SQ, He XL, He JX, Wang N. EDDM3A drives gastric cancer progression by promoting HIF-1α-dependent aerobic glycolysis. Oncogenesis. 11: 3. PMID 35039478 DOI: 10.1038/s41389-022-00379-6   
2022 Qian HG, Wu Q, Wu JH, Tian XY, Xu W, Hao CY. Long non‑coding RNA LINC00238 suppresses the malignant phenotype of liver cancer by sponging miR‑522. Molecular Medicine Reports. 25. PMID 35014686 DOI: 10.3892/mmr.2022.12587   
2022 Li C, Zhou T, Chen J, Li R, Chen H, Luo S, Chen D, Cai C, Li W. The role of Exosomal miRNAs in cancer. Journal of Translational Medicine. 20: 6. PMID 34980158 DOI: 10.1186/s12967-021-03215-4   
2022 Qin D, Ni C, Tan B, Huang S, Deng B, Huang Z. LINC01207 promotes prostate cancer progression by sponging miR-1182 to upregulate AKT3. Oncology Letters. 23: 57. PMID 34992689 DOI: 10.3892/ol.2021.13175   
2022 Xu F, Chen J, Huang D. Pan-cancer analysis identifies FAM49B as an immune-related prognostic maker for hepatocellular carcinoma. Journal of Cancer. 13: 278-289. PMID 34976189 DOI: 10.7150/jca.65421   
2022 Xu J, Su SM, Zhang X, Chan UI, Adhav R, Shu X, Liu J, Li J, Mo L, Wang Y, An T, Lei JH, Miao K, Deng CX, Xu X. ATP11B inhibits breast cancer metastasis in a mouse model by suppressing externalization of non-apoptotic phosphatidylserine. The Journal of Clinical Investigation. PMID 35025764 DOI: 10.1172/JCI149473   
2022 Yin L, Zhang Y, Zheng L. Analysis of differentially expressed long non‑coding RNAs revealed a pro‑tumor role of MIR205HG in cervical cancer. Molecular Medicine Reports. 25. PMID 34878159 DOI: 10.3892/mmr.2021.12558   
2022 Zhao Z, Shuang T, Gao Y, Lu F, Zhang J, He W, Qu L, Chen B, Hao Q. Targeted delivery of exosomal miR-484 reprograms tumor vasculature for chemotherapy sensitization. Cancer Letters. PMID 35051533 DOI: 10.1016/j.canlet.2022.01.011   
2022 Zou T, Wang Y, Dong L, Che T, Zhao H, Yan X, Lin Z. Stabilization of SETD3 by deubiquitinase USP27 enhances cell proliferation and hepatocellular carcinoma progression. Cellular and Molecular Life Sciences : Cmls. 79: 70. PMID 35018513 DOI: 10.1007/s00018-021-04118-9   
2022 Xiao Y, Yang K, Liu P, Ma D, Lei P, Liu Q. Deoxyribonuclease 1-like 3 Inhibits Hepatocellular Carcinoma Progression by Inducing Apoptosis and Reprogramming Glucose Metabolism. International Journal of Biological Sciences. 18: 82-95. PMID 34975319 DOI: 10.7150/ijbs.57919   
2022 Wei X, Hou Y, Zhang Y, Zhang H, Sun Z, Meng X, Wang Z. Long non-coding RNA MAGI2 inactivates STAT3 pathway to inhibit prostate cancer cell proliferation via acting as a microRNA-424-5p sponge. Journal of Cancer. 13: 343-353. PMID 34976194 DOI: 10.7150/jca.60749   
2022 Guo T, Zhang Z, Zhu L, Chen W, Ding Y, Li W, Huang Y, Huang J, Pan X. TRIM55 suppresses malignant biological behavior of lung adenocarcinoma cells by increasing protein degradation of Snail1. Cancer Biology & Therapy. 1-10. PMID 34974792 DOI: 10.1080/15384047.2021.2004835   
2022 Yi Q, Xie W, Sun W, Sun W, Liao Y. A Concise Review of MicroRNA-383: Exploring the Insights of Its Function in Tumorigenesis. Journal of Cancer. 13: 313-324. PMID 34976192 DOI: 10.7150/jca.64846   
2022 Inaishi T, Shibata M, Ichikawa T, Kanda M, Hayashi M, Soeda I, Takeuchi D, Takano Y, Tsunoda N, Kodera Y, Kikumori T. Platelet isoform of phosphofructokinase accelerates malignant features in breast cancer. Oncology Reports. 47. PMID 34751415 DOI: 10.3892/or.2021.8220   
2022 Yan Z, Xia X, Cho WC, Au DW, Shao X, Fang C, Tian Y, Lin Y. Rapid Plastic Deformation of Cancer Cells Correlates with High Metastatic Potential. Advanced Healthcare Materials. e2101657. PMID 35014196 DOI: 10.1002/adhm.202101657   
2022 Jia L, Lei B, Gao H, Jia L, Luo D, Han J, Jia B. miR-130b suppresses the invasion and migration of prostate cancer via inhibiting DLL1 and regulating the PI3K/Akt pathways. Experimental and Therapeutic Medicine. 23: 98. PMID 34976140 DOI: 10.3892/etm.2021.11021   
2022 Ding R, Duan Z, Yang M, Wang X, Li D, Kan Q. High miR-3609 expression is associated with better prognosis in TNBC based on mining using systematic integrated public sequencing data. Experimental and Therapeutic Medicine. 23: 54. PMID 34934431 DOI: 10.3892/etm.2021.10976   
2022 Dey A, Eisenberg S, Birnbaum R, Sharp DJ. 3D-on-2D: A Physiologically Relevant and Gel-Free In Vitro Coculture Method to Assay Antimetastatic Agents. Methods in Molecular Biology (Clifton, N.J.). 2423: 103-107. PMID 34978692 DOI: 10.1007/978-1-0716-1952-0_10   
2022 Pan G, Zhang K, Geng S, Lan C, Hu X, Li C, Ji H, Li C, Hu X, Wang Y, Lv M, Cui H. PHF14 knockdown causes apoptosis by inducing DNA damage and impairing the activity of the damage response complex in colorectal cancer. Cancer Letters. PMID 35074497 DOI: 10.1016/j.canlet.2022.01.002   
2022 Xiao L, Yuan W, Huang C, Luo Q, Xiao R, Chen ZH. LncRNA PCAT19 induced by SP1 and acted as oncogene in gastric cancer competitively binding to miR429 and upregulating DHX9. Journal of Cancer. 13: 102-111. PMID 34976174 DOI: 10.7150/jca.61961   
2022 Salvi A, Young AN, Huntsman AC, Pergande MR, Korkmaz MA, Rathnayake RA, Mize BK, Kinghorn AD, Zhang X, Ratia K, Schirle M, Thomas JR, Brittain SM, Shelton C, Aldrich LN, et al. PHY34 inhibits autophagy through V-ATPase V0A2 subunit inhibition and CAS/CSE1L nuclear cargo trafficking in high grade serous ovarian cancer. Cell Death & Disease. 13: 45. PMID 35013112 DOI: 10.1038/s41419-021-04495-w   
2022 Liu YM, Cao Y, Zhao PS, Wu LY, Lu YM, Wang YL, Zhao JF, Liu XG. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway. International Journal of Biological Sciences. 18: 637-651. PMID 35002514 DOI: 10.7150/ijbs.66915   
2022 Zhou Y, Wang C, Ding J, Chen Y, Sun Y, Cheng Z. miR-133a targets YES1 to reduce cisplatin resistance in ovarian cancer by regulating cell autophagy. Cancer Cell International. 22: 15. PMID 35012539 DOI: 10.1186/s12935-021-02412-x